Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

NCT02395666 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
140
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Giselle Sholler

Collaborators